MedAvail Holdings Inc
NASDAQ:MDVL
MedAvail Holdings Inc
Cost of Revenue
MedAvail Holdings Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MedAvail Holdings Inc
NASDAQ:MDVL
|
Cost of Revenue
-$22.2m
|
CAGR 3-Years
-237%
|
CAGR 5-Years
-152%
|
CAGR 10-Years
-36%
|
|
CareRx Corp
TSX:CRRX
|
Cost of Revenue
-CA$263.5m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-12%
|
|
Neighbourly Pharmacy Inc
TSX:NBLY
|
Cost of Revenue
-CA$456.4m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
See Also
What is MedAvail Holdings Inc's Cost of Revenue?
Cost of Revenue
-22.2m
USD
Based on the financial report for Jun 30, 2023, MedAvail Holdings Inc's Cost of Revenue amounts to -22.2m USD.
What is MedAvail Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-36%
Over the last year, the Cost of Revenue growth was -62%. The average annual Cost of Revenue growth rates for MedAvail Holdings Inc have been -237% over the past three years , -152% over the past five years , and -36% over the past ten years .